Nichole Reisdorph
Concepts (660)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 26 | 2025 | 733 | 4.280 |
Why?
| | Mass Spectrometry | 23 | 2025 | 731 | 2.180 |
Why?
| | Metabolome | 12 | 2023 | 391 | 1.950 |
Why?
| | Tandem Mass Spectrometry | 10 | 2023 | 572 | 1.730 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2024 | 638 | 1.320 |
Why?
| | Ion Mobility Spectrometry | 3 | 2020 | 5 | 1.280 |
Why?
| | Asthma | 12 | 2024 | 1797 | 1.220 |
Why?
| | Proteomics | 12 | 2019 | 1188 | 1.220 |
Why?
| | Proteome | 8 | 2019 | 513 | 1.110 |
Why?
| | Chromatography, High Pressure Liquid | 11 | 2025 | 592 | 1.110 |
Why?
| | Lipids | 6 | 2022 | 707 | 1.040 |
Why?
| | Ozone | 6 | 2025 | 116 | 1.020 |
Why?
| | Diet, Mediterranean | 2 | 2024 | 27 | 0.980 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.870 |
Why?
| | Tea | 1 | 2025 | 17 | 0.870 |
Why?
| | Research | 2 | 2018 | 431 | 0.840 |
Why?
| | Chromatography, Liquid | 11 | 2025 | 450 | 0.810 |
Why?
| | Biomarkers | 25 | 2024 | 4302 | 0.800 |
Why?
| | Amino Acids | 4 | 2020 | 519 | 0.790 |
Why?
| | Lung | 14 | 2025 | 4116 | 0.770 |
Why?
| | Eicosanoids | 4 | 2022 | 58 | 0.730 |
Why?
| | Blood Chemical Analysis | 3 | 2014 | 109 | 0.710 |
Why?
| | Metabolic Networks and Pathways | 5 | 2021 | 175 | 0.710 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 7 | 2022 | 920 | 0.690 |
Why?
| | Benz(a)Anthracenes | 1 | 2021 | 2 | 0.670 |
Why?
| | Benzopyrenes | 1 | 2021 | 4 | 0.670 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 1 | 2021 | 29 | 0.650 |
Why?
| | Animals | 60 | 2025 | 38097 | 0.650 |
Why?
| | Mice | 42 | 2025 | 18355 | 0.640 |
Why?
| | Pneumonia | 5 | 2025 | 636 | 0.640 |
Why?
| | Liquid-Liquid Extraction | 3 | 2018 | 13 | 0.630 |
Why?
| | Docosahexaenoic Acids | 5 | 2025 | 88 | 0.620 |
Why?
| | Dietary Supplements | 8 | 2026 | 584 | 0.620 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.610 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2026 | 174 | 0.610 |
Why?
| | Food | 2 | 2020 | 150 | 0.600 |
Why?
| | Breath Tests | 2 | 2017 | 77 | 0.590 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2191 | 0.580 |
Why?
| | Organic Chemicals | 1 | 2020 | 112 | 0.570 |
Why?
| | Phosphopeptides | 1 | 2018 | 19 | 0.560 |
Why?
| | Peptide Mapping | 1 | 2018 | 62 | 0.550 |
Why?
| | Databases, Chemical | 1 | 2018 | 9 | 0.550 |
Why?
| | Eicosapentaenoic Acid | 3 | 2024 | 37 | 0.540 |
Why?
| | Monocytes | 1 | 2021 | 539 | 0.540 |
Why?
| | Tyrosine | 1 | 2018 | 217 | 0.530 |
Why?
| | Isotope Labeling | 1 | 2018 | 82 | 0.520 |
Why?
| | Hypersensitivity | 4 | 2022 | 254 | 0.500 |
Why?
| | Tobacco Smoke Pollution | 2 | 2017 | 227 | 0.500 |
Why?
| | Pulmonary Emphysema | 4 | 2019 | 277 | 0.500 |
Why?
| | Macrophages | 3 | 2025 | 1507 | 0.490 |
Why?
| | Smoking | 7 | 2020 | 1477 | 0.490 |
Why?
| | Skin | 3 | 2018 | 754 | 0.490 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 768 | 0.490 |
Why?
| | Humans | 77 | 2026 | 145763 | 0.490 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2018 | 426 | 0.480 |
Why?
| | Plasma | 2 | 2017 | 223 | 0.480 |
Why?
| | Mice, Inbred C57BL | 14 | 2025 | 5992 | 0.450 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2020 | 125 | 0.450 |
Why?
| | Saliva | 1 | 2017 | 249 | 0.440 |
Why?
| | Glycerophospholipids | 4 | 2022 | 39 | 0.440 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 592 | 0.420 |
Why?
| | Salmon | 2 | 2025 | 21 | 0.420 |
Why?
| | Seafood | 2 | 2025 | 25 | 0.420 |
Why?
| | Peptides | 4 | 2019 | 998 | 0.420 |
Why?
| | Computational Biology | 3 | 2020 | 669 | 0.420 |
Why?
| | Leukotriene E4 | 3 | 2013 | 24 | 0.410 |
Why?
| | Alveolar Epithelial Cells | 3 | 2019 | 121 | 0.410 |
Why?
| | Mitochondria | 5 | 2023 | 992 | 0.400 |
Why?
| | Cell Differentiation | 2 | 2021 | 2050 | 0.390 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2013 | 27 | 0.380 |
Why?
| | Microbiota | 4 | 2022 | 730 | 0.380 |
Why?
| | Oxylipins | 4 | 2025 | 47 | 0.380 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 89 | 0.360 |
Why?
| | Cholesterol | 3 | 2024 | 408 | 0.360 |
Why?
| | Niacinamide | 2 | 2026 | 104 | 0.350 |
Why?
| | Endocannabinoids | 2 | 2022 | 56 | 0.350 |
Why?
| | Sirtuin 3 | 3 | 2023 | 60 | 0.350 |
Why?
| | Autoantigens | 4 | 2019 | 427 | 0.350 |
Why?
| | Software | 4 | 2020 | 680 | 0.340 |
Why?
| | Vitamins | 2 | 2025 | 184 | 0.340 |
Why?
| | Male | 45 | 2026 | 73003 | 0.330 |
Why?
| | Liver | 4 | 2020 | 1899 | 0.330 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3416 | 0.320 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2022 | 143 | 0.310 |
Why?
| | Sleep Deprivation | 2 | 2023 | 206 | 0.300 |
Why?
| | Transcriptome | 4 | 2022 | 1042 | 0.300 |
Why?
| | Immunoenzyme Techniques | 1 | 2009 | 200 | 0.290 |
Why?
| | Species Specificity | 2 | 2020 | 546 | 0.290 |
Why?
| | Analgesia | 1 | 2010 | 106 | 0.280 |
Why?
| | Blood Pressure | 5 | 2026 | 1782 | 0.280 |
Why?
| | Kainic Acid | 2 | 2018 | 33 | 0.260 |
Why?
| | Diet | 4 | 2024 | 1278 | 0.260 |
Why?
| | Female | 40 | 2026 | 79035 | 0.260 |
Why?
| | Minerals | 2 | 2025 | 48 | 0.260 |
Why?
| | Sensitivity and Specificity | 5 | 2017 | 2000 | 0.260 |
Why?
| | Workflow | 2 | 2020 | 183 | 0.260 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2025 | 508 | 0.260 |
Why?
| | Interleukin-13 | 3 | 2024 | 146 | 0.250 |
Why?
| | Cell Line | 8 | 2025 | 2823 | 0.250 |
Why?
| | Urinalysis | 2 | 2020 | 83 | 0.250 |
Why?
| | Chromatography, Ion Exchange | 1 | 2007 | 57 | 0.250 |
Why?
| | Inflammation Mediators | 2 | 2020 | 507 | 0.250 |
Why?
| | Mitochondrial Proteins | 2 | 2019 | 263 | 0.250 |
Why?
| | Pyrrolidines | 2 | 2025 | 125 | 0.240 |
Why?
| | Obesity | 7 | 2024 | 3118 | 0.240 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4568 | 0.240 |
Why?
| | Pilot Projects | 7 | 2026 | 1897 | 0.240 |
Why?
| | Amnesia | 1 | 2026 | 47 | 0.240 |
Why?
| | Middle Aged | 20 | 2025 | 36302 | 0.240 |
Why?
| | Ions | 1 | 2026 | 66 | 0.240 |
Why?
| | Mucus | 2 | 2024 | 75 | 0.230 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 368 | 0.230 |
Why?
| | Receptors, Lipoxin | 1 | 2025 | 6 | 0.230 |
Why?
| | Pulmonary Medicine | 1 | 2006 | 78 | 0.230 |
Why?
| | Dermatitis, Atopic | 3 | 2018 | 322 | 0.230 |
Why?
| | Phenylpropionates | 1 | 2025 | 27 | 0.230 |
Why?
| | Food Analysis | 1 | 2025 | 22 | 0.230 |
Why?
| | Diet, High-Fat | 3 | 2022 | 266 | 0.230 |
Why?
| | Receptors, Formyl Peptide | 1 | 2025 | 17 | 0.230 |
Why?
| | Sodium Nitrite | 2 | 2015 | 39 | 0.230 |
Why?
| | Body Fluids | 2 | 2017 | 71 | 0.230 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.220 |
Why?
| | Laboratories | 1 | 2026 | 110 | 0.220 |
Why?
| | Receptors, G-Protein-Coupled | 3 | 2021 | 231 | 0.220 |
Why?
| | Germ-Free Life | 1 | 2025 | 33 | 0.220 |
Why?
| | Fetal Growth Retardation | 2 | 2021 | 593 | 0.220 |
Why?
| | Metals, Heavy | 1 | 2025 | 31 | 0.220 |
Why?
| | Flavoproteins | 1 | 2004 | 8 | 0.210 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2004 | 4 | 0.210 |
Why?
| | Chlamydomonas reinhardtii | 1 | 2004 | 8 | 0.210 |
Why?
| | Membrane Microdomains | 1 | 2024 | 34 | 0.210 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2022 | 96 | 0.210 |
Why?
| | Ethanol | 2 | 2019 | 631 | 0.210 |
Why?
| | Agaricus | 1 | 2023 | 3 | 0.210 |
Why?
| | Lectins | 1 | 2024 | 44 | 0.200 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2016 | 1146 | 0.200 |
Why?
| | GPI-Linked Proteins | 1 | 2024 | 81 | 0.200 |
Why?
| | Bronchi | 1 | 2025 | 263 | 0.200 |
Why?
| | Solid Phase Extraction | 2 | 2014 | 25 | 0.200 |
Why?
| | Mucin 5AC | 1 | 2024 | 71 | 0.200 |
Why?
| | Feces | 2 | 2025 | 496 | 0.200 |
Why?
| | Islet Amyloid Polypeptide | 2 | 2016 | 48 | 0.200 |
Why?
| | Benzodioxoles | 1 | 2025 | 161 | 0.200 |
Why?
| | Eye Proteins | 1 | 2004 | 92 | 0.200 |
Why?
| | Oxadiazoles | 1 | 2003 | 37 | 0.200 |
Why?
| | Pyridines | 2 | 2025 | 609 | 0.200 |
Why?
| | Proteins | 3 | 2017 | 1023 | 0.200 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2020 | 143 | 0.200 |
Why?
| | Sleep | 4 | 2023 | 889 | 0.200 |
Why?
| | Mice, Knockout | 10 | 2025 | 3130 | 0.200 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2003 | 56 | 0.200 |
Why?
| | Isoxazoles | 1 | 2003 | 56 | 0.190 |
Why?
| | Rhinovirus | 1 | 2003 | 60 | 0.190 |
Why?
| | Quinolones | 1 | 2025 | 204 | 0.190 |
Why?
| | Epithelial Cells | 3 | 2025 | 1134 | 0.190 |
Why?
| | Capsid | 1 | 2003 | 94 | 0.190 |
Why?
| | Aminophenols | 1 | 2025 | 203 | 0.190 |
Why?
| | Plant Extracts | 1 | 2025 | 188 | 0.190 |
Why?
| | NAD | 2 | 2026 | 79 | 0.190 |
Why?
| | Arachidonic Acids | 1 | 2022 | 42 | 0.180 |
Why?
| | Acylation | 2 | 2019 | 30 | 0.180 |
Why?
| | Prostaglandins | 2 | 2022 | 94 | 0.180 |
Why?
| | Cells, Cultured | 6 | 2021 | 4151 | 0.180 |
Why?
| | Acute Lung Injury | 1 | 2025 | 307 | 0.180 |
Why?
| | Myocardium | 3 | 2019 | 935 | 0.180 |
Why?
| | Drosophila Proteins | 1 | 2004 | 214 | 0.180 |
Why?
| | Lipoxins | 1 | 2021 | 10 | 0.180 |
Why?
| | Linear Models | 2 | 2018 | 849 | 0.180 |
Why?
| | Oxidative Stress | 4 | 2021 | 1359 | 0.180 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 2 | 2020 | 37 | 0.170 |
Why?
| | Citrate (si)-Synthase | 1 | 2021 | 57 | 0.170 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2025 | 373 | 0.170 |
Why?
| | Bacterial Toxins | 1 | 2022 | 108 | 0.170 |
Why?
| | Indoles | 1 | 2025 | 507 | 0.170 |
Why?
| | Pyrazoles | 1 | 2025 | 517 | 0.170 |
Why?
| | Hippocampus | 2 | 2018 | 973 | 0.170 |
Why?
| | Dinoprostone | 1 | 2022 | 180 | 0.170 |
Why?
| | Orthomyxoviridae Infections | 2 | 2024 | 71 | 0.170 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2019 | 98 | 0.170 |
Why?
| | Brain Chemistry | 1 | 2021 | 120 | 0.170 |
Why?
| | Insulin-Secreting Cells | 3 | 2020 | 392 | 0.170 |
Why?
| | Calcifediol | 2 | 2022 | 31 | 0.170 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2022 | 159 | 0.170 |
Why?
| | Quantitative Trait Loci | 2 | 2021 | 381 | 0.170 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 25 | 0.170 |
Why?
| | Receptors, Scavenger | 1 | 2021 | 22 | 0.170 |
Why?
| | Amidohydrolases | 1 | 2021 | 31 | 0.170 |
Why?
| | Sepsis | 1 | 2007 | 664 | 0.160 |
Why?
| | Macrophages, Alveolar | 1 | 2024 | 373 | 0.160 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2021 | 52 | 0.160 |
Why?
| | Neuroprotection | 1 | 2021 | 46 | 0.160 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 32 | 0.160 |
Why?
| | Leukocytes, Mononuclear | 4 | 2022 | 574 | 0.160 |
Why?
| | Vitamin D Deficiency | 1 | 2022 | 190 | 0.160 |
Why?
| | Lipid Metabolism | 3 | 2018 | 529 | 0.160 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.160 |
Why?
| | Nasal Polyps | 1 | 2020 | 59 | 0.160 |
Why?
| | Cognitive Dysfunction | 1 | 2026 | 468 | 0.160 |
Why?
| | Phosphorylation | 4 | 2019 | 1708 | 0.160 |
Why?
| | Vital Capacity | 2 | 2018 | 292 | 0.150 |
Why?
| | Melatonin | 1 | 2021 | 163 | 0.150 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 85 | 0.150 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 131 | 0.150 |
Why?
| | Biotransformation | 1 | 2020 | 62 | 0.150 |
Why?
| | Aged | 12 | 2026 | 26215 | 0.150 |
Why?
| | Succinic Acid | 1 | 2019 | 46 | 0.150 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2021 | 127 | 0.150 |
Why?
| | Myofibrils | 1 | 2019 | 49 | 0.150 |
Why?
| | Neuroprotective Agents | 1 | 2021 | 147 | 0.150 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2019 | 15 | 0.150 |
Why?
| | Umbilical Arteries | 1 | 2020 | 52 | 0.150 |
Why?
| | Tubulin | 1 | 2020 | 146 | 0.150 |
Why?
| | Cross-Over Studies | 2 | 2020 | 610 | 0.150 |
Why?
| | Hyperinsulinism | 1 | 2020 | 115 | 0.150 |
Why?
| | Epithelium | 1 | 2020 | 311 | 0.150 |
Why?
| | Anthracenes | 1 | 2019 | 31 | 0.150 |
Why?
| | Uterine Artery | 1 | 2020 | 74 | 0.150 |
Why?
| | Lung Injury | 1 | 2022 | 249 | 0.140 |
Why?
| | Bacteria | 1 | 2025 | 766 | 0.140 |
Why?
| | Islets of Langerhans | 2 | 2019 | 847 | 0.140 |
Why?
| | Fluorenes | 1 | 2019 | 45 | 0.140 |
Why?
| | Insulin | 3 | 2022 | 2516 | 0.140 |
Why?
| | Bariatric Surgery | 1 | 2022 | 253 | 0.140 |
Why?
| | Inhalation Exposure | 2 | 2021 | 103 | 0.140 |
Why?
| | DNA End-Joining Repair | 1 | 2019 | 22 | 0.140 |
Why?
| | Neurodegenerative Diseases | 1 | 2021 | 143 | 0.140 |
Why?
| | Rhinitis | 1 | 2020 | 169 | 0.140 |
Why?
| | Dietary Proteins | 1 | 2020 | 135 | 0.140 |
Why?
| | Aging | 3 | 2023 | 1973 | 0.140 |
Why?
| | Liposomes | 1 | 2020 | 263 | 0.140 |
Why?
| | Microtubules | 1 | 2020 | 265 | 0.140 |
Why?
| | Synapses | 1 | 2022 | 439 | 0.140 |
Why?
| | Trypsin | 1 | 2018 | 75 | 0.140 |
Why?
| | Gene Expression | 4 | 2020 | 1478 | 0.140 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2018 | 42 | 0.140 |
Why?
| | Spleen | 1 | 2020 | 508 | 0.140 |
Why?
| | Leukotrienes | 1 | 2018 | 28 | 0.140 |
Why?
| | B-Lymphocyte Subsets | 1 | 2018 | 76 | 0.140 |
Why?
| | C-Peptide | 2 | 2016 | 190 | 0.140 |
Why?
| | Cysteine | 1 | 2019 | 211 | 0.130 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2018 | 38 | 0.130 |
Why?
| | Sinusitis | 1 | 2020 | 227 | 0.130 |
Why?
| | Limit of Detection | 1 | 2018 | 92 | 0.130 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 285 | 0.130 |
Why?
| | Adult | 15 | 2025 | 40872 | 0.130 |
Why?
| | Diet, Ketogenic | 1 | 2018 | 39 | 0.130 |
Why?
| | Flow Injection Analysis | 1 | 2017 | 6 | 0.130 |
Why?
| | Fatty Acids, Essential | 1 | 2017 | 2 | 0.130 |
Why?
| | Inflammasomes | 1 | 2018 | 144 | 0.130 |
Why?
| | Kynurenine | 1 | 2018 | 114 | 0.130 |
Why?
| | Adiponectin | 2 | 2022 | 242 | 0.130 |
Why?
| | Hydrolases | 1 | 2017 | 40 | 0.130 |
Why?
| | Sample Size | 1 | 2017 | 121 | 0.130 |
Why?
| | Health | 1 | 2017 | 82 | 0.130 |
Why?
| | Interleukin-6 | 2 | 2021 | 779 | 0.120 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 361 | 0.120 |
Why?
| | Nerve Growth Factors | 1 | 2017 | 79 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 624 | 0.120 |
Why?
| | Immunophenotyping | 2 | 2018 | 322 | 0.120 |
Why?
| | Disease | 1 | 2017 | 96 | 0.120 |
Why?
| | Proline | 1 | 2017 | 82 | 0.120 |
Why?
| | Antibodies | 1 | 2018 | 397 | 0.120 |
Why?
| | Sphingolipids | 1 | 2017 | 83 | 0.120 |
Why?
| | Autoimmunity | 2 | 2021 | 933 | 0.120 |
Why?
| | Artifacts | 1 | 2017 | 143 | 0.120 |
Why?
| | Hyperglycemia | 1 | 2020 | 379 | 0.120 |
Why?
| | Actins | 1 | 2018 | 426 | 0.120 |
Why?
| | Immunity, Humoral | 1 | 2017 | 118 | 0.120 |
Why?
| | Epitopes | 2 | 2016 | 473 | 0.120 |
Why?
| | Emphysema | 2 | 2013 | 100 | 0.120 |
Why?
| | Cardiomyopathies | 1 | 2019 | 335 | 0.120 |
Why?
| | Apoptosis | 4 | 2017 | 2443 | 0.120 |
Why?
| | Sex Characteristics | 1 | 2021 | 789 | 0.120 |
Why?
| | Acetylation | 3 | 2023 | 259 | 0.120 |
Why?
| | HEK293 Cells | 1 | 2018 | 741 | 0.120 |
Why?
| | Cytokines | 4 | 2025 | 2069 | 0.110 |
Why?
| | Vascular Stiffness | 2 | 2018 | 487 | 0.110 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 177 | 0.110 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2011 | 110 | 0.110 |
Why?
| | Arginine | 1 | 2017 | 264 | 0.110 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2016 | 174 | 0.110 |
Why?
| | Signal Transduction | 4 | 2022 | 5223 | 0.110 |
Why?
| | Amino Acid Sequence | 5 | 2016 | 2131 | 0.110 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 32 | 0.110 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.110 |
Why?
| | Electrophysiology | 1 | 2015 | 218 | 0.110 |
Why?
| | Respiratory Mucosa | 2 | 2024 | 322 | 0.110 |
Why?
| | Endoplasmic Reticulum | 1 | 2017 | 264 | 0.110 |
Why?
| | Chlorine | 1 | 2015 | 59 | 0.110 |
Why?
| | Forensic Sciences | 1 | 2014 | 3 | 0.110 |
Why?
| | Metabolic Syndrome | 1 | 2018 | 361 | 0.110 |
Why?
| | Aorta | 2 | 2015 | 440 | 0.110 |
Why?
| | Brain | 2 | 2018 | 2969 | 0.110 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 289 | 0.110 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 199 | 0.100 |
Why?
| | Carotid Arteries | 1 | 2015 | 208 | 0.100 |
Why?
| | Aged, 80 and over | 4 | 2026 | 8346 | 0.100 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 88 | 0.100 |
Why?
| | Interleukin-16 | 1 | 2013 | 6 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2022 | 1244 | 0.100 |
Why?
| | Lipopolysaccharides | 2 | 2025 | 858 | 0.100 |
Why?
| | Leukotriene Antagonists | 1 | 2013 | 24 | 0.100 |
Why?
| | Gangliosides | 1 | 2013 | 23 | 0.100 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 10 | 0.100 |
Why?
| | Up-Regulation | 2 | 2019 | 848 | 0.100 |
Why?
| | Lung Diseases | 2 | 2013 | 782 | 0.100 |
Why?
| | Education | 1 | 2013 | 105 | 0.100 |
Why?
| | Methyl Ethers | 1 | 2013 | 19 | 0.100 |
Why?
| | Adrenergic beta-Agonists | 1 | 2013 | 92 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 441 | 0.100 |
Why?
| | Methanol | 1 | 2013 | 44 | 0.100 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2019 | 3937 | 0.090 |
Why?
| | Health Status | 1 | 2018 | 835 | 0.090 |
Why?
| | Pyridinium Compounds | 2 | 2026 | 31 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2018 | 3634 | 0.090 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 192 | 0.090 |
Why?
| | Bronchodilator Agents | 1 | 2013 | 187 | 0.090 |
Why?
| | Nasal Mucosa | 2 | 2024 | 112 | 0.090 |
Why?
| | Hydroxyeicosatetraenoic Acids | 2 | 2022 | 35 | 0.090 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 1180 | 0.090 |
Why?
| | Alcohol Drinking | 1 | 2019 | 843 | 0.090 |
Why?
| | Mice, Inbred NOD | 4 | 2016 | 616 | 0.090 |
Why?
| | Heart Diseases | 1 | 2015 | 341 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2017 | 872 | 0.090 |
Why?
| | Epilepsy | 1 | 2016 | 390 | 0.090 |
Why?
| | Double-Blind Method | 3 | 2026 | 2064 | 0.090 |
Why?
| | Molecular Sequence Data | 4 | 2016 | 2883 | 0.090 |
Why?
| | Oxidation-Reduction | 3 | 2020 | 1068 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2021 | 1791 | 0.080 |
Why?
| | Calcium | 1 | 2017 | 1191 | 0.080 |
Why?
| | fas Receptor | 1 | 2011 | 91 | 0.080 |
Why?
| | Kaposi Varicelliform Eruption | 1 | 2011 | 21 | 0.080 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 346 | 0.080 |
Why?
| | Fatty Acids | 3 | 2018 | 457 | 0.080 |
Why?
| | Ovarian Follicle | 1 | 2011 | 78 | 0.080 |
Why?
| | Anti-Asthmatic Agents | 1 | 2013 | 260 | 0.080 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2018 | 331 | 0.080 |
Why?
| | Motor Activity | 1 | 2015 | 718 | 0.080 |
Why?
| | Pregnancy | 5 | 2025 | 7215 | 0.080 |
Why?
| | Aluminum | 1 | 2010 | 43 | 0.080 |
Why?
| | Mice, Obese | 2 | 2021 | 68 | 0.080 |
Why?
| | Rats | 4 | 2022 | 5585 | 0.080 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2010 | 55 | 0.080 |
Why?
| | Dietary Fats | 2 | 2022 | 308 | 0.080 |
Why?
| | Sarcomeres | 1 | 2010 | 97 | 0.080 |
Why?
| | E2F2 Transcription Factor | 1 | 2009 | 14 | 0.080 |
Why?
| | Light | 2 | 2021 | 403 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 1 | 2010 | 125 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2601 | 0.080 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2009 | 25 | 0.080 |
Why?
| | Chromogranin A | 1 | 2010 | 43 | 0.080 |
Why?
| | Ovary | 1 | 2011 | 234 | 0.070 |
Why?
| | Lymphocyte Activation | 3 | 2018 | 1133 | 0.070 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2009 | 79 | 0.070 |
Why?
| | Endothelium, Vascular | 1 | 2015 | 956 | 0.070 |
Why?
| | Adjuvants, Immunologic | 1 | 2010 | 244 | 0.070 |
Why?
| | Protein C | 1 | 2009 | 54 | 0.070 |
Why?
| | Binding Sites | 2 | 2020 | 1311 | 0.070 |
Why?
| | Glycoproteins | 1 | 2010 | 354 | 0.070 |
Why?
| | Sphingomyelins | 2 | 2020 | 22 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2010 | 337 | 0.070 |
Why?
| | Muscle Proteins | 1 | 2010 | 243 | 0.070 |
Why?
| | Group IV Phospholipases A2 | 2 | 2019 | 46 | 0.070 |
Why?
| | Sirtuins | 2 | 2019 | 50 | 0.070 |
Why?
| | Vasoconstriction | 1 | 2009 | 216 | 0.070 |
Why?
| | Reactive Oxygen Species | 2 | 2023 | 611 | 0.070 |
Why?
| | Interleukin-1beta | 2 | 2021 | 389 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2602 | 0.070 |
Why?
| | Glucose | 2 | 2023 | 1048 | 0.070 |
Why?
| | Transcriptional Activation | 1 | 2009 | 372 | 0.060 |
Why?
| | Inflammation | 3 | 2024 | 2883 | 0.060 |
Why?
| | Diet, Western | 2 | 2018 | 88 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2525 | 0.060 |
Why?
| | Pulmonary Fibrosis | 1 | 2011 | 395 | 0.060 |
Why?
| | Child | 6 | 2024 | 22739 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 2181 | 0.060 |
Why?
| | Cognition | 1 | 2015 | 1271 | 0.060 |
Why?
| | Disease Susceptibility | 2 | 2019 | 344 | 0.060 |
Why?
| | Biomedical Research | 1 | 2013 | 719 | 0.060 |
Why?
| | Phenotype | 4 | 2018 | 3170 | 0.060 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2013 | 923 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2008 | 364 | 0.060 |
Why?
| | Curriculum | 1 | 2013 | 1074 | 0.060 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 387 | 0.060 |
Why?
| | Staphylococcal Infections | 1 | 2011 | 393 | 0.060 |
Why?
| | Exercise | 1 | 2018 | 2205 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2326 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2010 | 696 | 0.060 |
Why?
| | Animal Feed | 1 | 2025 | 49 | 0.060 |
Why?
| | Fibroblasts | 1 | 2011 | 1027 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 19 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 56 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 33 | 0.060 |
Why?
| | Iodine | 1 | 2025 | 27 | 0.060 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1261 | 0.050 |
Why?
| | Algal Proteins | 1 | 2004 | 4 | 0.050 |
Why?
| | Drug Combinations | 1 | 2025 | 396 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2004 | 65 | 0.050 |
Why?
| | Choline | 1 | 2025 | 138 | 0.050 |
Why?
| | Gene Deletion | 1 | 2025 | 392 | 0.050 |
Why?
| | Cryptochromes | 1 | 2004 | 25 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2004 | 78 | 0.050 |
Why?
| | Antigen-Antibody Reactions | 1 | 2003 | 49 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 264 | 0.050 |
Why?
| | Oxazoles | 1 | 2003 | 48 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2240 | 0.050 |
Why?
| | Down-Regulation | 2 | 2020 | 618 | 0.050 |
Why?
| | Cerebrovascular Circulation | 1 | 2026 | 290 | 0.050 |
Why?
| | Protoplasts | 1 | 2003 | 6 | 0.050 |
Why?
| | Quality Control | 1 | 2023 | 161 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 638 | 0.050 |
Why?
| | Enzyme Activation | 2 | 2019 | 762 | 0.050 |
Why?
| | Introns | 1 | 2004 | 256 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2004 | 155 | 0.050 |
Why?
| | Cholesterol, HDL | 1 | 2023 | 201 | 0.050 |
Why?
| | Polyunsaturated Alkamides | 1 | 2022 | 7 | 0.050 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2022 | 9 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2003 | 414 | 0.050 |
Why?
| | Receptors, Cannabinoid | 1 | 2022 | 13 | 0.050 |
Why?
| | Virus Assembly | 1 | 2003 | 82 | 0.050 |
Why?
| | Exons | 1 | 2004 | 364 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1368 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 25 | 0.050 |
Why?
| | Seeds | 1 | 2003 | 69 | 0.050 |
Why?
| | Young Adult | 5 | 2020 | 14251 | 0.050 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2022 | 39 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 48 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2004 | 399 | 0.050 |
Why?
| | Mutation | 2 | 2004 | 4090 | 0.050 |
Why?
| | Cholecalciferol | 1 | 2022 | 61 | 0.050 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2022 | 38 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3551 | 0.040 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2022 | 130 | 0.040 |
Why?
| | HeLa Cells | 1 | 2003 | 632 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2008 | 1166 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2022 | 147 | 0.040 |
Why?
| | Immunity | 1 | 2022 | 140 | 0.040 |
Why?
| | Cattle | 1 | 2024 | 946 | 0.040 |
Why?
| | Polymorphism, Genetic | 1 | 2024 | 615 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2026 | 1137 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 18 | 0.040 |
Why?
| | 3T3-L1 Cells | 1 | 2020 | 36 | 0.040 |
Why?
| | Leptin | 1 | 2022 | 248 | 0.040 |
Why?
| | Adolescent | 4 | 2020 | 22573 | 0.040 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 58 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2020 | 62 | 0.040 |
Why?
| | Adenosine | 1 | 2022 | 255 | 0.040 |
Why?
| | Prescriptions | 1 | 2021 | 74 | 0.040 |
Why?
| | Sirtuin 2 | 1 | 2020 | 28 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 209 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2022 | 255 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 77 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 119 | 0.040 |
Why?
| | Receptors, Chemokine | 1 | 2020 | 48 | 0.040 |
Why?
| | Metaplasia | 1 | 2020 | 57 | 0.040 |
Why?
| | Neurons | 2 | 2023 | 1652 | 0.040 |
Why?
| | Placental Insufficiency | 1 | 2021 | 126 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2022 | 2967 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 212 | 0.040 |
Why?
| | Sex Factors | 2 | 2018 | 2110 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2020 | 43 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2022 | 292 | 0.040 |
Why?
| | Triglycerides | 1 | 2022 | 520 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2021 | 269 | 0.040 |
Why?
| | Calcium Signaling | 2 | 2015 | 245 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 145 | 0.040 |
Why?
| | Nutritional Sciences | 1 | 2020 | 34 | 0.040 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2020 | 57 | 0.040 |
Why?
| | Neutrophils | 1 | 2025 | 1125 | 0.040 |
Why?
| | Water | 1 | 2003 | 447 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 103 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2020 | 538 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 6032 | 0.040 |
Why?
| | Cellular Reprogramming | 1 | 2020 | 98 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 119 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 118 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2399 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 222 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 126 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 335 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2003 | 674 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 486 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 404 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 242 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 118 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 424 | 0.040 |
Why?
| | Interferons | 1 | 2020 | 186 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2020 | 142 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 876 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2003 | 560 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 312 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 58 | 0.040 |
Why?
| | Cilia | 1 | 2020 | 172 | 0.040 |
Why?
| | Fibrinogen | 2 | 2010 | 180 | 0.040 |
Why?
| | Metagenomics | 1 | 2020 | 149 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2018 | 165 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 265 | 0.030 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 167 | 0.030 |
Why?
| | Germinal Center | 1 | 2018 | 64 | 0.030 |
Why?
| | Microglia | 1 | 2021 | 273 | 0.030 |
Why?
| | GTP Phosphohydrolases | 1 | 2018 | 93 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2021 | 896 | 0.030 |
Why?
| | Models, Molecular | 1 | 2003 | 1599 | 0.030 |
Why?
| | Caspase 1 | 1 | 2018 | 145 | 0.030 |
Why?
| | Native Polyacrylamide Gel Electrophoresis | 1 | 2018 | 3 | 0.030 |
Why?
| | Naphthoquinones | 1 | 2018 | 20 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2019 | 365 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 295 | 0.030 |
Why?
| | Methionine | 1 | 2018 | 161 | 0.030 |
Why?
| | Phospholipase A2 Inhibitors | 1 | 2017 | 3 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2018 | 149 | 0.030 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 2123 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1330 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 166 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2018 | 322 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1547 | 0.030 |
Why?
| | Nutritional Status | 1 | 2020 | 353 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 305 | 0.030 |
Why?
| | Energy Intake | 1 | 2020 | 512 | 0.030 |
Why?
| | Transfection | 1 | 2019 | 927 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1751 | 0.030 |
Why?
| | Forensic Medicine | 1 | 2017 | 19 | 0.030 |
Why?
| | Fetus | 1 | 2021 | 804 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 37 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2017 | 2805 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2018 | 234 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 859 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 334 | 0.030 |
Why?
| | Circadian Rhythm | 1 | 2021 | 513 | 0.030 |
Why?
| | RNA-Binding Proteins | 2 | 2011 | 447 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2018 | 133 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 504 | 0.030 |
Why?
| | Escherichia coli | 1 | 2020 | 835 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 420 | 0.030 |
Why?
| | Gestational Age | 1 | 2020 | 989 | 0.030 |
Why?
| | Influenza A virus | 1 | 2017 | 119 | 0.030 |
Why?
| | Family | 1 | 2021 | 685 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1217 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2017 | 563 | 0.030 |
Why?
| | Methemoglobin | 1 | 2015 | 24 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 265 | 0.030 |
Why?
| | DNA Damage | 1 | 2019 | 437 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 318 | 0.030 |
Why?
| | Body Mass Index | 2 | 2015 | 2447 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2017 | 335 | 0.030 |
Why?
| | Clone Cells | 1 | 2016 | 263 | 0.030 |
Why?
| | Cystic Fibrosis | 1 | 2025 | 1163 | 0.030 |
Why?
| | Etiocholanolone | 1 | 2015 | 5 | 0.030 |
Why?
| | Ranolazine | 1 | 2015 | 23 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Gerbillinae | 1 | 2015 | 72 | 0.030 |
Why?
| | Thiocyanates | 1 | 2015 | 28 | 0.030 |
Why?
| | Elasticity | 1 | 2015 | 189 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2933 | 0.030 |
Why?
| | Placenta | 1 | 2021 | 787 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2021 | 1430 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2015 | 267 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2015 | 94 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 830 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1812 | 0.030 |
Why?
| | Prospective Studies | 2 | 2021 | 8075 | 0.030 |
Why?
| | Brachial Artery | 1 | 2015 | 208 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 835 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 361 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 440 | 0.030 |
Why?
| | Mitochondria, Heart | 1 | 2015 | 107 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 11868 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2933 | 0.030 |
Why?
| | Salmeterol Xinafoate | 1 | 2013 | 20 | 0.030 |
Why?
| | Fluticasone | 1 | 2013 | 53 | 0.020 |
Why?
| | Time Factors | 2 | 2019 | 7133 | 0.020 |
Why?
| | Cyclopropanes | 1 | 2013 | 84 | 0.020 |
Why?
| | Pregnenolone | 1 | 2013 | 3 | 0.020 |
Why?
| | Androstadienes | 1 | 2013 | 77 | 0.020 |
Why?
| | Immune Tolerance | 1 | 2016 | 385 | 0.020 |
Why?
| | Albuterol | 1 | 2013 | 76 | 0.020 |
Why?
| | Acetates | 1 | 2013 | 78 | 0.020 |
Why?
| | Disease Progression | 1 | 2021 | 2865 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2013 | 318 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2028 | 0.020 |
Why?
| | Sulfides | 1 | 2013 | 92 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 428 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 337 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4556 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2015 | 500 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2013 | 207 | 0.020 |
Why?
| | Vasodilation | 1 | 2015 | 521 | 0.020 |
Why?
| | Forced Expiratory Volume | 1 | 2013 | 450 | 0.020 |
Why?
| | Quinolines | 1 | 2013 | 190 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2018 | 935 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2013 | 440 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 371 | 0.020 |
Why?
| | Mesocricetus | 1 | 2011 | 52 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 61 | 0.020 |
Why?
| | Antioxidants | 1 | 2015 | 550 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 138 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1925 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2026 | 11793 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 305 | 0.020 |
Why?
| | Eosinophils | 1 | 2013 | 316 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 159 | 0.020 |
Why?
| | Regression Analysis | 1 | 2013 | 1001 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 849 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2015 | 892 | 0.020 |
Why?
| | Salts | 1 | 2010 | 35 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 484 | 0.020 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 81 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2015 | 546 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 52 | 0.020 |
Why?
| | Fibrin | 1 | 2010 | 84 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 571 | 0.020 |
Why?
| | Surgical Tape | 1 | 2009 | 5 | 0.020 |
Why?
| | Endothelin-Converting Enzymes | 1 | 2009 | 10 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2009 | 32 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2013 | 784 | 0.020 |
Why?
| | Metalloendopeptidases | 1 | 2009 | 63 | 0.020 |
Why?
| | alpha-2-HS-Glycoprotein | 1 | 2009 | 2 | 0.020 |
Why?
| | Immunoglobulin J-Chains | 1 | 2009 | 6 | 0.020 |
Why?
| | Thrombin | 1 | 2010 | 172 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 219 | 0.020 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2009 | 30 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 302 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5922 | 0.020 |
Why?
| | Haptoglobins | 1 | 2009 | 71 | 0.020 |
Why?
| | Risk | 1 | 2011 | 923 | 0.020 |
Why?
| | Albumins | 1 | 2009 | 119 | 0.020 |
Why?
| | Phosphotyrosine | 1 | 2008 | 38 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 6464 | 0.020 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 104 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2009 | 181 | 0.020 |
Why?
| | Drug Interactions | 1 | 2009 | 405 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 92 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1491 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 174 | 0.020 |
Why?
| | Nanotechnology | 1 | 2008 | 114 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 239 | 0.020 |
Why?
| | Protein Conformation | 1 | 2010 | 938 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2011 | 453 | 0.020 |
Why?
| | Lymphoma | 1 | 2008 | 241 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 598 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2011 | 910 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 440 | 0.010 |
Why?
| | Age Factors | 1 | 2013 | 3346 | 0.010 |
Why?
| | Cell Membrane | 1 | 2009 | 709 | 0.010 |
Why?
| | Algorithms | 1 | 2013 | 1850 | 0.010 |
Why?
| | Histones | 1 | 2010 | 666 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2009 | 892 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1247 | 0.010 |
Why?
| | United States | 1 | 2022 | 16123 | 0.010 |
Why?
| | Pyrimidines | 1 | 2008 | 530 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1777 | 0.010 |
Why?
| | Raffinose | 1 | 2003 | 29 | 0.010 |
Why?
| | Germination | 1 | 2003 | 8 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2770 | 0.010 |
Why?
| | Sucrose | 1 | 2003 | 114 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1997 | 0.010 |
Why?
| | Vaccination | 1 | 2010 | 1428 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1505 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 10917 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 6085 | 0.010 |
Why?
|
|
Reisdorph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|